Logo image of LNSR

LENSAR INC (LNSR) Stock News

NASDAQ:LNSR - Nasdaq - US52634L1089 - Common Stock - Currency: USD

13.58  0 (0%)

After market: 13.58 0 (0%)

LNSR Latest News, Press Relases and Analysis

News Image
2 months ago - LENSAR, Inc.

Alcon Agrees to Acquire LENSAR, Inc.

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolioNext generation technology will be...

News Image
21 days ago - LENSAR, Inc.

LENSAR Reports First Quarter 2025 Results and Provides Business Update

         14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of...

News Image
2 months ago - Yahoo Finance

Is LENSAR (LNSR) a Deeply Undervalued Stock?

Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 0.38% in the first quarter compared to -4.27% for the S&P 500 and -9.51% for the Russell 2000. In addition, please check the fund’s top five holdings to know […]

Mentions: NVDA TSLA

News Image
2 months ago - Benzinga

Alcon Eyes Surgical Edge With LENSAR Buyout: Details

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract surgery.

Mentions: ALC

News Image
2 months ago - Alcon Inc. Investors

Alcon Agrees to Acquire LENSAR, Inc.

Mentions: ALC

News Image
3 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...

News Image
3 months ago - LENSAR, Inc.

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total...

News Image
3 months ago - LENSAR, Inc.

LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on...

News Image
4 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...

News Image
5 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...

News Image
6 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...

News Image
6 months ago - LENSAR, Inc.

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on...

News Image
7 months ago - LENSAR, Inc.

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

         24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending...

News Image
7 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...

News Image
7 months ago - LENSAR, Inc.

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on...

News Image
8 months ago - LENSAR, Inc.

One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems

ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on...

News Image
8 months ago - LENSAR, Inc.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the...